Trial
NCT04070781
Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
Incyte Corporation
Condition
Steroid Refractory GVHD
Intervention
Itacitinib
Why stopped
The primary reason for study closure is slow enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-04